ArticleThe mental health clinician2025
Safety considerations for patients using cannabis.
Article in The mental health clinician, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis is the most used federally illicit substance in the United States, yet there is limited knowledge about its pharmacology; efficacy for various medical conditions; or, more importantly, its safety profile. There is significant interest in exploring the full extent of the pharmacologic effects of cannabinoids. Psychoactive effects of cannabis are well-established, but the other effects of cannabinoids, including their effect on mood symptoms; suicidal ideation; and activity outside of the central nervous system, including actions on the cardiovascular system, are still being uncovered. With an increasing number of states in the United States independently authorizing medicinal and, in some cases, recreational use of cannabis, it is essential that our health care professionals are aware of these potential risks when caring for patients who are using cannabis. The objective of this manuscript is to describe how mood symptoms, suicidality, cardiovascular effects, and drug interactions may be associated with cannabis use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.